Tuberous Sclerosis Alliance
Based in MD
🤖
AI Overview
With $960K in lobbying spend across 32 quarterly filings, Tuberous Sclerosis Alliance is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2018 to 2025.
$960K
Total Spend
8
Years Active
1
Firms Hired
2
Lobbyists Deployed
4
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $120K |
| 2019 | $120K |
| 2020 | $120K |
| 2021 | $120K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $120K |
| 2025 | $120K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Tuberous Sclerosis Alliance disclosed contacting in their lobbying filings.
HOUSE OF REPRESENTATIVESNatl Institutes of Health (NIH)SENATECenters For Disease Control & Prevention (CDC)
View all agency pressure data →What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Budget/Appropriations, MED, Defense
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
Similar Clients
The National Alliance for Eye and Vision Research
$2.0M total spend
Lieber Institute for Brain Development
$400K total spend
Hereditary Hemorrhagic Telangiectasia Foundation
$330K total spend
The United States Pharmacopeial Convention
$2.6M total spend
Association of Independent Research Institutes
$1.5M total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.